Schizophrenia

Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
Psychedelics And Schizophrenia: What's The Link?
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
Psychedelics And Schizophrenia: What's The Link?
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial

Schizophrenia Recent News

FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
The FDA has notified Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) that it m
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
Neurocrine Biosciences Inc (NASDAQ: NBIX) has 
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
FDA Approves First And Only Twice-Yearly Schizophrenia Drug
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
Cerevel Therapeutics Stock Shoots Higher As Schizophrenia Treatment Tops Placebo On Antipsychotic Activity
Alkermes Shares Move Higher On FDA Approval Of Schizophrenia, Bipolar Med
BioXcel's Formulated Dexmedetomidine US Application For Agitation Under FDA Review
Minerva Shares Surge As Schizophrenia Candidate Shows Long Term Improvement In Negative Symptoms, Functioning
Reviva Pharma Stock Trading Higher On Detailed Positive Schizophrenia Study Results
Neurocrine/Takeda's Luvadaxistat Fails To Improve Schizophrenia Symptom Severity
Neurocrine Biosciences Inc (NASDAQ: NBIX) 
Psychedelics And Schizophrenia: What's The Link?
This article by Derek Beres was originally published on Psychedelic Spotlight, and appears here with permission. Psychedelics and schizophrenia share a history. Now, researchers are looking at how psychedelics may change the future. Can psychedelics help treat schizophrenia?
UPDATE: JMP Securities Initiates Coverage On Intra-Cellular Therapies